Iterum Therapeutics Plc (NASDAQ:ITRM) currently has a daily average trading volume of 2.64M but it saw 2353188 shares traded in last market. With a market cap of 78.14M USD, the company’s current market price of $2.84 came rising about 18.83 while comparing to the previous closing price of $2.39. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.52 and as low as $0.81. In the recent trading on the day, stock has struck highest price mark of $2.4 while lowest mark touched by it was $2.95.
Taking a look at 20-day trading activity of Iterum Therapeutics Plc (ITRM) gives us an average price of $1.79, while its current price level is 12.70% below from 52-week high level whereas it is 251.49% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.40 while that of 200 days or SMA-200 reads an average of $1.36. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.71% during that period while stretching the period over a month that decreases to 12.18%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 80.76 which implies that the stock is in overbought territory.
H.C. Wainwright upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 15, 2021 while assigning a price target of $2.50. RBC Capital Mkts issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $7 and $2.
Over the week, ITRM’s stock price is moving 39.90% up while it is 120.16% when we observe its performance for the past one month. Year-to-date it is 44.16% up and over the past year, the stock is showing an upside performance of 34.60%.
Currently, Iterum Therapeutics Plc’s total number of outstanding shares is 27.52M. Company’s return on equity (ROE) at -555.68%. Stock’s beta reads 2.31. Its return on asset (ROA) is -109.80% on average.
